Digestive Remedies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for digestive remedies. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Digestive Remedies Market Size (2024E): USD 19731.861 Mn
Projected Market Value (2033F): USD 28574.426 Mn
Global Market Growth Rate (CAGR 2024 to 2033): 4.2 %

Digestive Remedies Market - Report Scope:

Digestive remedies include a broad range of products aimed at treating digestive health issues such as indigestion, acid reflux, constipation, and irritable bowel syndrome (IBS). The market is segmented by product type, including antacids, laxatives, anti-diarrheal drugs, and probiotics, and by end-use sectors such as retail pharmacies, hospital pharmacies, and e-commerce platforms.

Market Growth Drivers:

The global digestive remedies market is driven by rising incidences of digestive disorders and lifestyle diseases, which have led to a surge in demand for over-the-counter (OTC) digestive products. Increasing consumer awareness of gut health and the growing preference for self-medication have also supported the expansion of this market. Aging populations in several regions are more prone to digestive problems, further boosting the demand for digestive remedies. Additionally, the rising consumption of processed foods, sedentary lifestyles, and stress are contributing to the increasing prevalence of digestive issues, driving growth in the market. Technological advancements in product formulations, including the introduction of herbal and natural digestive remedies, are also appealing to health-conscious consumers.

Market Restraints:

Despite significant growth potential, the digestive remedies market faces challenges such as stringent regulatory requirements and concerns about the side effects of long-term use of certain digestive drugs, particularly laxatives and antacids. Fluctuations in raw material prices and the high cost of some advanced digestive treatments also pose limitations to market growth. Furthermore, the growing preference for natural remedies and dietary supplements as alternatives to pharmaceutical digestive products could limit the growth of traditional digestive remedies in some regions. To address these challenges, market players are focusing on developing safe, natural, and innovative digestive health products.

Market Opportunities:

The digestive remedies market presents several growth opportunities, particularly in the area of probiotics and prebiotics, which are increasingly recognized for their role in maintaining gut health. The growing interest in preventive healthcare, along with consumer demand for natural and plant-based digestive solutions, offers significant opportunities for innovation and product development. The expanding e-commerce sector also provides an opportunity for market players to reach a broader consumer base, offering easy access to OTC digestive remedies. Furthermore, the increasing focus on personalized medicine and targeted therapies for specific digestive issues, such as IBS and Crohn's disease, is opening up new avenues for market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the digestive remedies market globally?
Which product types are witnessing the highest demand in the digestive remedies sector?
How are technological advancements and product innovations influencing the competitive landscape?
Who are the key players in the digestive remedies market, and what strategies are they using to maintain market relevance?
What emerging trends and opportunities will shape the future of the digestive remedies market?

Competitive Intelligence and Business Strategy:

Leading players in the global digestive remedies market, including Bayer AG, GlaxoSmithKline Plc, and Johnson & Johnson, are focusing on expanding their product portfolios with a range of digestive health solutions, including both traditional pharmaceuticals and natural remedies. These companies are investing in research and development to create innovative formulations with improved efficacy and fewer side effects. Collaborations with healthcare professionals, pharmacies, and e-commerce platforms are key strategies for promoting digestive remedies to a broader audience. Furthermore, sustainability initiatives, such as eco-friendly packaging and responsible sourcing of natural ingredients, are gaining importance as consumer preferences shift towards more environmentally conscious products.

Companies Covered in This Report

Johnson & Johnson, Inc
Bayer AG
Sanofi
Procter & Gamble Co.
Jiangzhong Pharmaceutical Co Ltd
Abbott Laboratories Inc.
Reckitt Benckiser Group Plc (RB)
Takeda Pharmaceutical Co Ltd.
Pfizer
GlaxoSmithKline Plc
Menarini Group
Taisho Pharmaceutical Holdings Co Ltd.
Purdue Pharma LP

Digestive Remedies Industry Research by Category

By Product Type:

Capsules
Liquid/Drinkable
Powder
Gels
Others(Pills, Tablet, Gummy)

By Nature:

Organic
Conventional

By Source:

Prebiotic
Probiotic
Food Enzymes

By Sales Channel:

Pharmaceutical & Drug Store
Hypermarket/Supermarket
Convenience Store
Direct Store
Online Retail
Other Retail Format

By Region:

North America
Latin America
Europe
South Asia & Pacific
East Asia
Middle East & Africa

Product Code: PMRREP30469

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market
- 3.1.1. Increasing Consumer Awareness on Benefits of Prebiotics
- 3.1.2. High Demand of Pediatric Digestive Enzymes
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features

5. Global Market - Pricing Analysis

5.1. Regional Pricing Analysis
5.2. Global Average Pricing Analysis Benchmark

6. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
- 6.2.1. Y-o-Y Growth Trend Analysis
- 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

7.1. Macro-Economic Factors
- 7.1.1. Global GDP Growth Outlook
- 7.1.2. Global GDP and Infrastructure Investment
- 7.1.3. International Trade
- 7.1.4. Global Industry Outlook
7.2. Forecast Factors - Relevance & Impact
- 7.2.1. Top Companies Historical Growth
- 7.2.2. GDP Growth forecast
- 7.2.3. Manufacturing Industry forecast
- 7.2.4. Global Urbanization Growth Outlook
- 7.2.5. Business Climate
7.3. Value Chain
- 7.3.1. Raw Material Suppliers
- 7.3.2. Product Manufacturers
- 7.3.3. Application Sectors
7.4. Global Food & Beverage Industry Outlook
7.5. Global Pharmaceutical Industry Overview
7.6. Policy Developments and Regulatory Scenario
7.7. Market Dynamics
- 7.7.1. Drivers
- 7.7.2. Restraints
- 7.7.3. Opportunity Analysis
7.8. Global Supply Demand Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

8.1. Introduction
8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2033
- 8.3.1. Capsules
- 8.3.2. Liquid/Drinkable
- 8.3.3. Powder
- 8.3.4. Gels
- 8.3.5. Others (Pills, Tablet, Gummy)
8.4. Market Attractiveness Analysis By Product Type

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Source

9.1. Introduction
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Source, 2019-2023
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Source, 2024-2033
- 9.3.1. Prebiotic
- 9.3.2. Probiotic
- 9.3.3. Food Enzymes
9.4. Market Attractiveness Analysis By Source

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Nature

10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Nature, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Nature, 2024-2033
- 10.3.1. Organic
- 10.3.2. Conventional
10.4. Market Attractiveness Analysis By Nature

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Sales Channel

11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2019-2023
11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2024-2033
- 11.3.1. Pharmaceutical & Drug Store
- 11.3.2. Hypermarket/Supermarket
- 11.3.3. Convenience Store
- 11.3.4. Direct Store
- 11.3.5. Online Retail
- 11.3.6. Other Retail Format
11.4. Market Attractiveness Analysis By Sales Channel

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. East Asia
- 12.3.5. South Asia and Pacific
- 12.3.6. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. U.S.
  - 13.3.1.2. Canada
- 13.3.2. By Product Type
- 13.3.3. By Source
- 13.3.4. By Nature
- 13.3.5. By Sales Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product Type
- 13.4.3. By Source
- 13.4.4. By Nature
- 13.4.5. By Sales Channel
13.5. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Brazil
  - 14.3.1.2. Mexico
  - 14.3.1.3. Argentina
  - 14.3.1.4. Rest of Latin America
- 14.3.2. By Product Type
- 14.3.3. By Source
- 14.3.4. By Nature
- 14.3.5. By Sales Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product Type
- 14.4.3. By Source
- 14.4.4. By Nature
- 14.4.5. By Sales Channel
14.5. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. Germany
  - 15.3.1.2. Italy
  - 15.3.1.3. France
  - 15.3.1.4. U.K.
  - 15.3.1.5. Spain
  - 15.3.1.6. BENELUX
  - 15.3.1.7. Russia
  - 15.3.1.8. Poland
  - 15.3.1.9. Rest of Europe
- 15.3.2. By Product Type
- 15.3.3. By Source
- 15.3.4. By Nature
- 15.3.5. By Sales Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Product Type
- 15.4.2. By Source
- 15.4.3. By Nature
- 15.4.4. By Sales Channel
15.5. Drivers and Restraints - Impact Analysis

16. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. ASEAN
  - 16.3.1.3. Oceania
  - 16.3.1.4. Rest of South Asia & Pacific
- 16.3.2. By Product Type
- 16.3.3. By Source
- 16.3.4. By Nature
- 16.3.5. By Sales Channel
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product Type
- 16.4.3. By Source
- 16.4.4. By Nature
- 16.4.5. By Sales Channel
16.5. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Product Type
- 17.3.3. By Source
- 17.3.4. By Nature
- 17.3.5. By Sales Channel
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product Type
- 17.4.3. By Source
- 17.4.4. By Nature
- 17.4.5. By Sales Channel
17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. GCC
  - 18.3.1.2. Turkey
  - 18.3.1.3. Nigeria
  - 18.3.1.4. South Africa
  - 18.3.1.5. Rest of Middle East & Africa
- 18.3.2. By Product Type
- 18.3.3. By Source
- 18.3.4. By Nature
- 18.3.5. By Sales Channel
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product Type
- 18.4.3. By Source
- 18.4.4. By Nature
- 18.4.5. By Sales Channel
18.5. Drivers and Restraints - Impact Analysis

19. Country Wise Market Analysis, 2024

19.1. Introduction
- 19.1.1. Market Value Proportion Analysis, By Key Countries
- 19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Market Analysis
- 19.2.1. By Product Type
- 19.2.2. By Source
- 19.2.3. By Nature
- 19.2.4. By Sales Channel
19.3. Canada Market Analysis
- 19.3.1. By Product Type
- 19.3.2. By Source
- 19.3.3. By Nature
- 19.3.4. By Sales Channel
19.4. Mexico Market Analysis
- 19.4.1. By Product Type
- 19.4.2. By Source
- 19.4.3. By Nature
- 19.4.4. By Sales Channel
19.5. Brazil Market Analysis
- 19.5.1. By Product Type
- 19.5.2. By Source
- 19.5.3. By Nature
- 19.5.4. By Sales Channel
19.6. Argentina Market Analysis
- 19.6.1. By Product Type
- 19.6.2. By Source
- 19.6.3. By Nature
- 19.6.4. By Sales Channel
19.7. Germany Market Analysis
- 19.7.1. By Product Type
- 19.7.2. By Source
- 19.7.3. By Nature
- 19.7.4. By Sales Channel
19.8. Italy Market Analysis
- 19.8.1. By Product Type
- 19.8.2. By Source
- 19.8.3. By Nature
- 19.8.4. By Sales Channel
19.9. France Market Analysis
- 19.9.1. By Product Type
- 19.9.2. By Source
- 19.9.3. By Nature
- 19.9.4. By Sales Channel
19.10. U.K. Market Analysis
- 19.10.1. By Product Type
- 19.10.2. By Source
- 19.10.3. By Nature
- 19.10.4. By Sales Channel
19.11. Spain Market Analysis
- 19.11.1. By Product Type
- 19.11.2. By Source
- 19.11.3. By Nature
- 19.11.4. By Sales Channel
19.12. Poland Market Analysis
- 19.12.1. By Product Type
- 19.12.2. By Source
- 19.12.3. By Nature
- 19.12.4. By Sales Channel
19.13. Russia Market Analysis
- 19.13.1. By Product Type
- 19.13.2. By Source
- 19.13.3. By Nature
- 19.13.4. By Sales Channel
19.14. China Market Analysis
- 19.14.1. By Product Type
- 19.14.2. By Source
- 19.14.3. By Nature
- 19.14.4. By Sales Channel
19.15. Japan Market Analysis
- 19.15.1. By Product Type
- 19.15.2. By Source
- 19.15.3. By Nature
- 19.15.4. By Sales Channel
19.16. S. Korea Market Analysis
- 19.16.1. By Product Type
- 19.16.2. By Source
- 19.16.3. By Nature
- 19.16.4. By Sales Channel
19.17. India Market Analysis
- 19.17.1. By Product Type
- 19.17.2. By Source
- 19.17.3. By Nature
- 19.17.4. By Sales Channel
19.18. Australia and New Zealand Market Analysis
- 19.18.1. By Product Type
- 19.18.2. By Source
- 19.18.3. By Nature
- 19.18.4. By Sales Channel
19.19. Turkey Market Analysis
- 19.19.1. By Product Type
- 19.19.2. By Source
- 19.19.3. By Nature
- 19.19.4. By Sales Channel
19.20. South Africa Market Analysis
- 19.20.1. By Product Type
- 19.20.2. By Source
- 19.20.3. By Nature
- 19.20.4. By Sales Channel

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies (Digestive Remedies)
20.2. Market Concentration
20.3. Market Presence Analysis

21. Competition Analysis

21.1. Competition Dashboard
21.2. Competition Deep Dive
- 21.2.1. Johnson & Johnson, Inc.
  - 21.2.1.1. Overview
  - 21.2.1.2. Product Portfolio
  - 21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.1.4. Sales Footprint
  - 21.2.1.5. Strategy Overview
- 21.2.2. Bayer AG
  - 21.2.2.1. Overview
  - 21.2.2.2. Product Portfolio
  - 21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.2.4. Sales Footprint
  - 21.2.2.5. Strategy Overview
- 21.2.3. Sanofi
  - 21.2.3.1. Overview
  - 21.2.3.2. Product Portfolio
  - 21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.3.4. Sales Footprint
  - 21.2.3.5. Strategy Overview
- 21.2.4. Procter & Gamble Co.
  - 21.2.4.1. Overview
  - 21.2.4.2. Product Portfolio
  - 21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.4.4. Sales Footprint
  - 21.2.4.5. Strategy Overview
- 21.2.5. Jiangzhong Pharmaceutical Co Ltd
  - 21.2.5.1. Overview
  - 21.2.5.2. Product Portfolio
  - 21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.5.4. Sales Footprint
  - 21.2.5.5. Strategy Overview
- 21.2.6. Abbott Laboratories Inc.
  - 21.2.6.1. Overview
  - 21.2.6.2. Product Portfolio
  - 21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.6.4. Sales Footprint
  - 21.2.6.5. Strategy Overview
- 21.2.7. Reckitt Benckiser Group Plc (RB)
  - 21.2.7.1. Overview
  - 21.2.7.2. Product Portfolio
  - 21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.7.4. Sales Footprint
  - 21.2.7.5. Strategy Overview
- 21.2.8. Takeda Pharmaceutical Co Ltd.
  - 21.2.8.1. Overview
  - 21.2.8.2. Product Portfolio
  - 21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.8.4. Sales Footprint
  - 21.2.8.5. Strategy Overview
- 21.2.9. Pfizer
  - 21.2.9.1. Overview
  - 21.2.9.2. Product Portfolio
  - 21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.9.4. Sales Footprint
  - 21.2.9.5. Strategy Overview
- 21.2.10. GlaxoSmithKline Plc
  - 21.2.10.1. Overview
  - 21.2.10.2. Product Portfolio
  - 21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.10.4. Sales Footprint
  - 21.2.10.5. Strategy Overview
- 21.2.11. Menarini Group
  - 21.2.11.1. Overview
  - 21.2.11.2. Product Portfolio
  - 21.2.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.11.4. Sales Footprint
  - 21.2.11.5. Strategy Overview
- 21.2.12. Taisho Pharmaceutical Holdings Co Ltd.
  - 21.2.12.1. Overview
  - 21.2.12.2. Product Portfolio
  - 21.2.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.12.4. Sales Footprint
  - 21.2.12.5. Strategy Overview
- 21.2.13. Purdue Pharma LP
  - 21.2.13.1. Overview
  - 21.2.13.2. Product Portfolio
  - 21.2.13.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.13.4. Sales Footprint
  - 21.2.13.5. Strategy Overview
- 21.2.14. Others (Available on Request)
  - 21.2.14.1. Overview
  - 21.2.14.2. Product Portfolio
  - 21.2.14.3. Profitability by Market Segments (Product/Channel/Region)
  - 21.2.14.4. Sales Footprint
  - 21.2.14.5. Strategy Overview